1c2k
RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
|
OverviewOverview
Many serine proteases are targets for therapeutic intervention because, they often play key roles in disease. Small molecule inhibitors of serine, proteases with high affinity are especially interesting as they could be, used as scaffolds from which to develop drugs selective for protease, targets. One such inhibitor is bis(5-amidino-2-benzimidazolyl)methane, (BABIM), standing out as the best inhibitor of trypsin (by a factor of, over 100) in a series of over 60 relatively closely related analogues. By, probing the structural basis of inhibition, we discovered, using, crystallographic methods, a new mode of high-affinity binding in which a, Zn2+ ion is tetrahedrally coordinated between two chelating nitrogens of, BABIM and two active site residues, His57 and Ser 195. Zn2+, at, subphysiological levels, enhances inhibition by over 10(3)-fold. The, distinct Zn2+ coordination geometry implies a strong dependence of, affinity on substituents. This unique structural paradigm has enabled, development of potent, highly selective, Zn2+-dependent inhibitors of, several therapeutically important serine proteases, using a, physiologically ubiquitous metal ion.
About this StructureAbout this Structure
1C2K is a Single protein structure of sequence from Bos taurus with CA, CL, ZN and ABI as ligands. Active as Trypsin, with EC number 3.4.21.4 Full crystallographic information is available from OCA.
ReferenceReference
Design of potent selective zinc-mediated serine protease inhibitors., Katz BA, Clark JM, Finer-Moore JS, Jenkins TE, Johnson CR, Ross MJ, Luong C, Moore WR, Stroud RM, Nature. 1998 Feb 5;391(6667):608-12. PMID:9468142
Page seeded by OCA on Tue Nov 20 12:06:45 2007